USD 1bln needed for production of one branded medicine June 8, 2011 - 12:59 AMT PanARMENIAN.Net - GXP Center of Excellence Director, Editor-in-Chief of Pharma magazine Aram Ghazaryan said active development of the pharmaceutical field has started in Armenia since its independence. According to him, huge investments were made to the field during this period. Ghazaryan noted that 14 companies operate in Armenia, while their output is sold in both local and foreign markets, specifically, of the CIS countries. He added that the quality of locally produced medicines is in compliance with international standards. Almost all types of medicines are currently produced in Armenia, but USD 1bln is needed for production of one branded medicine, said Chairman the Union of Armenian Medicines Producers and Importers Samvel Zakaryan. Top stories Yerevan has dismissed Turkey’s demand to shut down the Armenian nuclear power plant as “inappropriate”. Armenia will loan 2.9 billion drams to Nagorno Karabakh (Artsakh), according to a draft government decision. The Ministry of Ecology and Natural Resources of Azerbaijan has “strongly condemned” Armenia’s decision. Kerobyan has said that for the first time in the history of Armenia, the volume of foreign direct investments amounted to about $1 billion. Partner news | Armenian, Iranian foreigh policy chief talk over the phone The Foreign Minister of Armenia once again expressed condolences to his counterpart on the death of the President of Iran. Armenia, U.S. customs authorities to boost assistance with new deal The government has approved an agreement with the U.S. government on mutual assistance between the customs authorities. Armenian government besieged by protesters Protesters led by Archbishop Bagrat Galstanyan poured into Yerevan’s Republic Square to try to surround the seat of Armenia’s government. EU calls on Azerbaijan to release all political prisoners The European Union calls on Azerbaijan to release all those imprisoned for exercising their fundamental rights. |